CORCEPT THERAPEUTICS INC — Director's Dealing 2018

Nov 14, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2018-11-09

Reporting Person: BAKER G LEONARD JR (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-09	Common Stock	P	17428.0000	$13.0000	Acquired	894266.0000	Direct
2018-11-12	Common Stock	P	31677.0000	$12.9434	Acquired	925943.0000	Direct
2018-11-13	Common Stock	P	10895.0000	$12.8680	Acquired	936838.0000	Direct
2018-11-09	Common Stock	P	40666.0000	$13.0000	Acquired	2875459.0000	Indirect
2018-11-12	Common Stock	P	73914.0000	$12.9434	Acquired	2949373.0000	Indirect
2018-11-13	Common Stock	P	25420.0000	$12.8680	Acquired	2974793.0000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	955055.0000	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.99 to $13.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.72 to $13.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.75 to $13.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F4: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

F5: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.